Published in Bipolar Disord on May 01, 2012
Nonhuman primate model of schizophrenia using a noninvasive EEG method. Proc Natl Acad Sci U S A (2013) 1.03
Decreased spectral entropy modulation in patients with schizophrenia during a P300 task. Eur Arch Psychiatry Clin Neurosci (2014) 0.85
Altered visual information processing systems in bipolar disorder: evidence from visual MMN and P3. Front Hum Neurosci (2013) 0.81
Patterns of deficits in brain function in bipolar disorder and schizophrenia: a cluster analytic study. Psychiatry Res (2012) 0.80
Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis. PLoS One (2012) 0.80
Disorder-specific and shared neurophysiological impairments of attention and inhibition in women with attention-deficit/hyperactivity disorder and women with bipolar disorder. Psychol Med (2015) 0.78
Decreased empathy response to other people's pain in bipolar disorder: evidence from an event-related potential study. Sci Rep (2017) 0.75
The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study. Int J Neuropsychopharmacol (2015) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol (1983) 12.44
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Copy-number variations associated with neuropsychiatric conditions. Nature (2008) 6.78
Spherical splines for scalp potential and current density mapping. Electroencephalogr Clin Neurophysiol (1989) 6.17
Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria. Psychophysiology (2000) 5.83
Early selective-attention effect on evoked potential reinterpreted. Acta Psychol (Amst) (1978) 4.13
Developing constructs for psychopathology research: research domain criteria. J Abnorm Psychol (2010) 3.79
Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res (1998) 3.69
The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci Biobehav Rev (2001) 3.26
When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol (2009) 2.59
Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry (2004) 2.37
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry (2000) 2.26
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A (1996) 2.22
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci (2009) 1.89
Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry (2005) 1.87
Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry (2008) 1.83
Prefrontal cortex involvement in preattentive auditory deviance detection: neuroimaging and electrophysiological evidence. Neuroimage (2003) 1.71
Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch Gen Psychiatry (2002) 1.66
Assessing levels of adaptive functioning: the Role Functioning Scale. Community Ment Health J (1993) 1.54
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett (1980) 1.48
Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry (1991) 1.48
Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry (2000) 1.41
Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biol Psychiatry (2006) 1.34
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res (2006) 1.34
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport (2001) 1.31
Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry (1995) 1.29
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci (2007) 1.28
Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am J Psychiatry (2010) 1.25
How specific are deficits in mismatch negativity generation to schizophrenia? Biol Psychiatry (2003) 1.18
Advances in endophenotyping schizophrenia. World Psychiatry (2008) 1.18
Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med (2011) 1.18
Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry (2010) 1.16
Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biol Psychiatry (2002) 1.13
Sound frequency change detection in fetuses and newborns, a magnetoencephalographic study. Neuroimage (2005) 1.12
The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clin Neurophysiol (2009) 1.12
Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry (1998) 1.09
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl) (2008) 1.09
Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence. Arch Gen Psychiatry (1990) 1.06
Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med (2009) 1.05
P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change. Biol Psychiatry (1998) 1.03
Phonetic mismatch negativity predicts social skills acquisition in schizophrenia. Psychiatry Res (2007) 1.02
Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.02
Evidence for the auditory P3a reflecting an automatic process: elicitation during highly-focused continuous visual attention. Brain Res (2007) 0.99
Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmacol (1999) 0.99
Mismatch responses to randomized gradient switching noise as reflected by fMRI and whole-head magnetoencephalography. Hum Brain Mapp (2002) 0.97
Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. Int J Neuropsychopharmacol (2008) 0.92
MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord (2000) 0.92
Mechanisms for detecting auditory temporal and spectral deviations operate over similar time windows but are divided differently between the two hemispheres. Neuroimage (2006) 0.89
Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder. Bipolar Disord (2008) 0.88
MMN elicitation during natural sleep to violations of an auditory pattern. Brain Res (2009) 0.88
Impaired temporal lobe processing of preattentive auditory discrimination in schizophrenia. Schizophr Bull (2002) 0.86
Mismatch negativity and N100 in comatose patients. Audiol Neurootol (2000) 0.84
Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge. J Psychiatry Neurosci (2001) 0.84
Event-related potentials reveal a memory trace for temporal features. Neuroreport (1993) 0.83
Can mismatch negativity be linked to synaptic processes? A glutamatergic approach to deviance detection. Brain Cogn (2007) 0.83
Right Hemispheric Contributions to Fine Auditory Temporal Discriminations: High-Density Electrical Mapping of the Duration Mismatch Negativity (MMN). Front Integr Neurosci (2009) 0.82
Auditory cortex evoked magnetic fields and lateralization of speech processing. Neuroreport (2000) 0.77
Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A (2009) 16.93
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull (2005) 4.66
ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp (2005) 4.25
Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry (2009) 4.22
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res (2007) 3.79
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage (2009) 3.66
The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry (2008) 3.29
Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling. J Neurosci (2009) 3.21
Behavioral interpretations of intrinsic connectivity networks. J Cogn Neurosci (2011) 3.09
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Biosocial pathways to functional outcome in schizophrenia. Schizophr Res (2005) 2.65
Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci (2012) 2.57
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry (2007) 2.45
Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry (2006) 2.42
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry (2006) 2.29
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Metaanalytic connectivity modeling: delineating the functional connectivity of the human amygdala. Hum Brain Mapp (2010) 2.27
The poor prognosis of childhood-onset bipolar disorder. J Pediatr (2007) 2.26
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry (2013) 2.24
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry (2008) 2.17
Nonconscious and conscious color priming in schizophrenia. J Psychiatr Res (2012) 2.08
Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv (2007) 1.99
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93
Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry (2002) 1.93
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord (2010) 1.90
Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull (2003) 1.89
Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. Am J Psychiatry (2006) 1.88
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging (2006) 1.87
Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry (2002) 1.84
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse. Bipolar Disord (2009) 1.82
Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data: validation of the Lancaster transform. Neuroimage (2010) 1.82
Affective traits in schizophrenia and schizotypy. Schizophr Bull (2008) 1.81
Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res (2006) 1.80
Retrospective motion correction protocol for high-resolution anatomical MRI. Hum Brain Mapp (2006) 1.80
Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage (2013) 1.78
Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull (2006) 1.75
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry (2004) 1.72
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol (2006) 1.71
From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68
Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res (2006) 1.67
Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry (2012) 1.62
On the genetic architecture of cortical folding and brain volume in primates. Neuroimage (2010) 1.62
Regional fMRI hypoactivation and altered functional connectivity during emotion processing in nonmedicated depressed patients with bipolar II disorder. Am J Psychiatry (2012) 1.61
Placental passage of antidepressant medications. Am J Psychiatry (2003) 1.61
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res (2004) 1.59
The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res (2006) 1.57
Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry (2005) 1.57
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry (2005) 1.56
Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull (2011) 1.56
The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord (2012) 1.54
How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull (2007) 1.53
Prefrontal activation deficits during episodic memory in schizophrenia. Am J Psychiatry (2009) 1.53
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry (2010) 1.51
Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res (2010) 1.50
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disord (2011) 1.50
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry (2002) 1.48
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord (2007) 1.46
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). Psychiatry Res (2007) 1.45
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry (2005) 1.44
Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord (2003) 1.44
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry (2003) 1.44
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res (2008) 1.41
The functional connectivity of the human caudate: an application of meta-analytic connectivity modeling with behavioral filtering. Neuroimage (2011) 1.41
Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull (2011) 1.38
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull (2010) 1.36
Genetics of the connectome. Neuroimage (2013) 1.33
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry (2004) 1.33
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophr Bull (2008) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. J Psychiatr Res (2009) 1.30
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Social perception and early visual processing in schizophrenia. Schizophr Res (2003) 1.30
Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex (2006) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res (2004) 1.27
Measuring and comparing brain cortical surface area and other areal quantities. Neuroimage (2012) 1.27
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology (2007) 1.27